Pulmonary Hypertension for Certified Emergency Nursing (CEN)
Included In This Lesson
Outline
Pulmonary Hypertension
Definition/Etiology:
Normal mean pulmonary artery pressure is 12-16 mmHg.
Pulmonary hypertension is >20 mmHg.
Five groups of Pulmonary Hypertension:
- Group 1: pulmonary arterial (PA) hypertension (PAH), which has several causes (eg, inheritable causes, drugs, connective tissue disease)
- Group 2: due to left-sided heart failure (most common PH)
- Group 3: due to chronic lung disorders and hypoxemia
- Group 4: due to acute or chronic PE
- Group 5: due to unidentified mechanisms
Pathophysiology:
- Pulmonary arterial hypertension (group 1): small pulmonary muscular arterioles develop vasoconstriction, hyperplasia, hypertrophy, fibrosis, and thrombosis that involves all three layers of the vascular wall.
- Pulmonary hypertension:
Group 2–elevated left-sided pressure backs up into the pulmonary system. - Group 3–restrictive (kyphosis), obstructive (COPD), hypoxia (sleep apnea, obesity hypoventilation)
- Group 4–rare (1%) complication of PE. Poorly understood. Not related to genetic hypercoagulable states.
Clinical Presentation:
- Exertional dyspnea / chest pain / syncope
- Lethargy / fatigue
Right-sided heart failure signs and symptoms:
- Ascites / hepatomegaly
- Leg edema
- Early satiety
- RUQ pain
Collaborative Management:
- EKG: right axis deviation due to RV/RA enlargement
- CXR: pleural effusions
- Labs: elevated BNP
- Echocardiogram: RV strain, tricuspid regurg
- Accurate history: travel, cocaine, diet pills, cigarettes, HIV, connective tissue disease, sleep apnea, prior DVT/PE
- Possible left and right heart catheterization
- Pulmonary function test
- Sleep study
- VQ scan or CT angio chest (PE protocol)
- Treat underlying process (anticoagulation if from PEs, CPAP if from apnea, diuretics if from CHF, oxygen if from hypoxia)
- Smoking cessation
- Pulmonary rehab / exercise
- Lung transplantation for Group 3
- Heart transplantation for Group 2 (or LVAD)
- Cardiology consult
Evaluation | Patient Monitoring | Education:
- Oxygen saturation monitoring
- Home infusion of IV medications for Group 1
- Transplant center referral PRN
- Importance of follow-up on sleep study / apnea treatment
- Drug / smoking cessation / counseling / support
- Home oxygen use and teaching re: safety
- Importance of exercise / pulmonary rehab
Linchpins: (Key Points)
- Treat underlying disease.
- Thin right ventricular wall can’t push against high pressures.
- Pressure in pulmonary system should be quite low.
- Group 1 (PAH) is really bad.
- LOTS of things can cause PH/PAH. You don’t have to memorize all of the groups and causes.
Transcript
For more great CEN prep, got to the link below to purchase the “Emergency Nursing Examination Review” book by Dr. Laura Gasparis Vonfrolio RN, PHD
https://greatnurses.com/
References:
- Fedullo, P. F. (2022, March 11). Epidemiology, pathogenesis, clinical manifestations and diagnosis of chronic thromboembolic pulmonary hypertension. UpToDate. https://www.uptodate.com/contents/epidemiology-pathogenesis-clinical-manifestations-and-diagnosis-of-chronic-thromboembolic-pulmonary-hypertension
- Hopkins, W. (2022, September 26). Treatment of pulmonary arterial hypertension (group 1) in adults: Pulmonary hypertension-specific therapy. UpToDate. https://www.uptodate.com/contents/treatment-of-pulmonary-arterial-hypertension-group-1-in-adults-pulmonary-hypertension-specific-therapy
- Krishnan, U (2022, June 8). Pulmonary hypertension due to left heart disease (group 2 pulmonary hypertension) in adults. UpToDate. https://www.uptodate.com/contents/pulmonary-hypertension-due-to-left-heart-disease-group-2-pulmonary-hypertension-in-adults
- Rubin, L. J. (2022, September 26). Clinical features and diagnosis of pulmonary hypertension of unclear etiology in adults. UpToDate. https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-pulmonary-hypertension-of-unclear-etiology-in-adults
- Rubin, L. J. (2021, November 8). The epidemiology and pathogenesis of pulmonary arterial hypertension (Group 1). UpToDate. https://www.uptodate.com/contents/the-epidemiology-and-pathogenesis-of-pulmonary-arterial-hypertension-group-1
- Ryu, J. H. (2022, September 7). Pulmonary hypertension due to lung disease and/or hypoxemia (group 3 pulmonary hypertension): Treatment and prognosis. UpToDate. https://www.uptodate.com/contents/pulmonary-hypertension-due-to-lung-disease-and-or-hypoxemia-group-3-pulmonary-hypertension-treatment-and-prognosis